APA (7th ed.) Citation

Y, G., Y, B., X, M., & X, P. (2026). Efficacy and safety of small interfering RNA (siRNA) therapies for hypertriglyceridemia and mixed dyslipidemia: An updated systematic review and meta-analysis. Frontiers in pharmacology, 17, 1736821. https://doi.org/10.3389/fphar.2026.1736821

Chicago Style (17th ed.) Citation

Y, Gao, Bai Y, Mu X, and Pang X. "Efficacy and Safety of Small Interfering RNA (siRNA) Therapies for Hypertriglyceridemia and Mixed Dyslipidemia: An Updated Systematic Review and Meta-analysis." Frontiers in Pharmacology 17 (2026): 1736821. https://doi.org/10.3389/fphar.2026.1736821.

MLA (9th ed.) Citation

Y, Gao, et al. "Efficacy and Safety of Small Interfering RNA (siRNA) Therapies for Hypertriglyceridemia and Mixed Dyslipidemia: An Updated Systematic Review and Meta-analysis." Frontiers in Pharmacology, vol. 17, 2026, p. 1736821, https://doi.org/10.3389/fphar.2026.1736821.